Compared to the prevalence reported in the literature, a statistically significant (P < 0.05) lower incidence of the following individual thrombophilia markers was observed: a heterozygous mutation in the FV gene, elevated Lp(a) levels, antiphospholipid syndrome, and elevated activity of factor VIII. This evidence concerns the gene F5 and thrombophilia.